ALEJANDRO
OLIVARES HERNÁNDEZ
Researcher from 2019
Lorena
Bellido Hernández
Profesora Asociada CC. Salud
Publications by the researcher in collaboration with Lorena Bellido Hernández (13)
2025
-
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors
Clinical and Translational Oncology
-
Corrigendum to “Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review” [Clin. Translat. Radiat. Oncol. 52 (2025) 100930](S2405630825000205)(10.1016/j.ctro.2025.100930)
Clinical and Translational Radiation Oncology
-
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
Precision Cancer Medicine, Vol. 7, pp. 1-13
-
Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review
Clinical and Translational Radiation Oncology, Vol. 52
-
Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort study
Translational Lung Cancer Research, Vol. 14, Núm. 7, pp. 2494-2508
2024
-
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
Precision Cancer Medicine, pp. 1-13
-
Cáncer de pulmón
Oncología clínica (Arán), pp. 227-257
-
Melanoma maligno
Oncología clínica (Arán), pp. 381-394
-
Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%
Translational Lung Cancer Research, Vol. 13, Núm. 10, pp. 2649-2659
2023
-
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
Cancers, Vol. 15, Núm. 17
-
Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Chinese Clinical Oncology, Vol. 12, Núm. 6
2022
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2